KMKerry R. Mills

Kerry R. Mills

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kerry R. Mills has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A novel central motor conduction abnormality in D90A‐homozygous patients with amyotrophic lateral sclerosis

    by Abena D. Osei‐Lah, Martin R. Turner, Peter M. Andersen, P. Nigel Leigh, Kerry R. Mills

    Patients with amyotrophic lateral sclerosis (ALS) who are homozygous for the D90A SOD1 mutation have been noted to have central motor abnormalities distinct from those of patients with idiopathic ALS. We stimulated the motor cortex of ten patients homozygous for the D90A SOD1 mutation, using transcranial magnetic stimulation (TMS), and recorded the response evoked in the right first dorsal interosseous muscle when the muscle was at rest and when voluntarily active. A subgroup of patients had two distinct evoked responses when the cortex was stimulated at high intensity with the muscle at rest. When the muscle was modestly contracted, the first of these responses disappeared, whereas the second response was facilitated. Both fast and slow components of the corticospinal tract were usually intact and excited by TMS in these patients. We propose that there is an abnormality of intracortical or intraspinal inhibition in a subgroup of D90A SOD1 ALS patients, which suppresses fast‐conducted activity when the muscle is active. Apart from further defining the phenotype of familial ALS, these findings may have importance in understanding the pathogenesis of central motor abnormalities in these patients. Muscle Nerve 29: 790–794, 2004


  • Open Access

    The natural history of central motor abnormalities in amyotrophic lateral sclerosis

    by K. R. Mills

    Degeneration of spinal motoneurons has been well documented in amyotrophic lateral sclerosis (ALS), but the evolution of central motor abnormalities is largely unknown. It has been suggested that glutamate‐ mediated neuroexcitotoxicity may be involved in the pathogenesis of ALS and that this may be manifest as an increase in corticomotor excitability early in the disease. Serial measurements of corticomotor threshold, central motor conduction time (CMCT), silent period duration and the amplitude of compound muscle action potentials (CMAPs) from ulnar nerve stimulation in the right and left first dorsal interosseous muscles were made in 76 patients with idiopathic ALS, 49 of whom were followed from presentation to death. Threshold to transcranial magnetic stimulation was determined by standard methods and CMCT was measured using the F‐wave method. Silent period was estimated during a small background contraction of the muscle. Patients were classified according to the region of onset and the physical signs in the hands. The region of onset was bulbar in 17 patients, lower limb in 31 patients and upper limb in 28 patients. At presentation, 23 patients had no abnormal physical signs in the hands, 25 had lower motoneuron signs only, 14 had upper motoneuron signs only and the remainder (14) had mixed upper and lower motoneuron signs in the hands. Evolution of the central conduction parameters was determined in relation to time from onset of symptoms and also as a function of normalized total disease duration in the patients who had died. Corticomotor threshold and CMCT showed no change as the disease evolved except for patients with mixed signs, who had a terminal increase in threshold and prolongation of CMCT. Silent period duration was shorter than normal early in the disease and showed progressive lengthening throughout the illness, but nevertheless remained within the normal range regardless of the region of onset. CMAP amplitude showed a linear decline over the course of the disease. There was therefore no evidence of a phase of increased corticomotor hyperexcitability at any stage of disease progression. The early shortening of silent period, however, probably represents a shift in the balance of excitatory and inhibitory inputs to the cortical output cells responsible for voluntary action, and could be a reflection of degeneration of cortical interneurons. None of the measures of central motor function in ALS are likely to be useful for monitoring patients in a clinical trial setting.


  • Further evidence for corticomotor hyperexcitability in amyotrophic lateral sclerosis

    by Daisuke Naka, Kerry R. Mills

    A collision experiment has been used to investigate repetitive firing of first dorsal interosseous motoneurons following a single transcranial magnetic stimulus (TMS) in healthy subjects and patients with amyotrophic lateral sclerosis (ALS). An appropriately timed supramaximal peripheral nerve shock blocks the first descending impulses in the motor axons and allows the response due to repetitive firing to be quantified. Multiple firing of motoneurons in healthy subjects increases as TMS intensity rises and saturates at about 1.25 times threshold. Increasing background force also augments repetitive firing and saturates at force levels above 50% maximum. The ratio of the area of the response attributed to repetitive motoneuron firing to the area of the initial direct response to TMS was compared in 10 ALS patients and 10 healthy controls. In ALS patients, the ratio was significantly higher (P = 0.0005), indicating a greater degree of repetitive firing of motoneurons. This suggests that, in ALS, there is corticomotor hyperexcitability either at the spinal motoneuron or motor cortex. © 2000 John Wiley & Sons, Inc. Muscle Nerve 23: 1044–1050, 2000